BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24993701)

  • 1. Telomere dysfunction and hematologic disorders.
    Paiva RM; Calado RT
    Prog Mol Biol Transl Sci; 2014; 125():133-57. PubMed ID: 24993701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
    Polychronopoulou S; Koutroumba P
    Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase and telomere biology in hematological diseases: A new therapeutic target.
    Allegra A; Innao V; Penna G; Gerace D; Allegra AG; Musolino C
    Leuk Res; 2017 May; 56():60-74. PubMed ID: 28196338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomeres and marrow failure.
    Calado RT
    Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia.
    Bär C; Povedano JM; Serrano R; Benitez-Buelga C; Popkes M; Formentini I; Bobadilla M; Bosch F; Blasco MA
    Blood; 2016 Apr; 127(14):1770-9. PubMed ID: 26903545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
    Ballew BJ; Savage SA
    Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomeres, telomerase, and hematopoietic stem cell biology.
    Greenwood MJ; Lansdorp PM
    Arch Med Res; 2003; 34(6):489-95. PubMed ID: 14734088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of telomere biology in bone marrow failure and other disorders.
    Savage SA; Alter BP
    Mech Ageing Dev; 2008; 129(1-2):35-47. PubMed ID: 18160098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow failure and the new telomere diseases: practice and research.
    Young NS
    Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
    Drummond MW; Balabanov S; Holyoake TL; Brummendorf TH
    Stem Cells; 2007 Aug; 25(8):1853-61. PubMed ID: 17510216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
    Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
    N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.
    Vasko T; Kaifie A; Stope MB; Kraus T; Ziegler P
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29143804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere maintenance and human bone marrow failure.
    Calado RT; Young NS
    Blood; 2008 May; 111(9):4446-55. PubMed ID: 18239083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and Management of Hematopoietic Failure in Dyskeratosis Congenita.
    Agarwal S
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):669-685. PubMed ID: 30047419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomeres and telomerase in normal and leukemic hematopoietic cells.
    Engelhardt M; Wäsch R; Guo Y
    Leuk Res; 2004 Oct; 28(10):1001-4. PubMed ID: 15289009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
    Hao LY; Armanios M; Strong MA; Karim B; Feldser DM; Huso D; Greider CW
    Cell; 2005 Dec; 123(6):1121-31. PubMed ID: 16360040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics and clinical manifestations of telomere biology disorders.
    Savage SA; Bertuch AA
    Genet Med; 2010 Dec; 12(12):753-64. PubMed ID: 21189492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
    Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
    Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.